Physician

Eric Matthew Zavaleta, M.D.

According to 2025 Medicare claims, Eric Zavaleta, M.D. (NPI: 1619141363) practices ophthalmology in the Abilene, TX market, with the plurality of this provider's patient population coming from Taylor, TX. This provider's primary affiliated billing organization is OPHTHALMOLOGY SPECIALISTS OF TEXAS, PLLC (NPI: 1902836166; TIN: 450466456) and primary practice location at 79606-1224. Zavaleta is affiliated with the CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Zavaleta's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,230 traditional Medicare patients, billed 22,470 HCPCS/CPT codes, and received $2,494,934 in Medicare payments. The top billing code was 92235 (Exam of retinal blood vessels using a special camera after injection of a dye). Part D data shows 918 prescription claims across 223 beneficiaries totaling $32,083 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 4 records totaling $166. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $583,974 to $2,494,934. Similarly, Part D prescription costs have risen steadily, from $18,195 to $32,083. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	574	6,376	$583,974
2016	1,193	10,220	$1,121,548
2017	1,278	12,813	$1,323,129
2018	1,041	10,550	$1,054,577
2019	1,076	10,747	$1,336,836
2020	1,049	9,510	$1,353,253
2021	1,219	10,564	$1,444,002
2022	1,193	9,803	$1,195,543
2023	1,174	18,288	$1,987,013
2024	1,230	22,470	$2,494,934

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	143	354	$18,195
2016	242	615	$27,290
2017	161	679	$29,589
2018	143	609	$26,572
2019	143	639	$34,834
2020	170	720	$40,298
2021	207	792	$35,429
2022	227	925	$37,524
2023	222	833	$31,526
2024	223	918	$32,083

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
92235	Exam of retinal blood vessels using a special camera after injection of a dye	266	291	$122
92014	Established patient complete exam of visual system	748	1,079	$98
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	868	1,792	$87
67028	Injection of drug into eye	357	2,103	$86
92134	Imaging of retina	1,193	3,102	$30

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Prednisolone Acetate	Prednisolone Acetate	190	5,893	$5,584
Difluprednate	Difluprednate	20	537	$2,344
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	89	5,325	$2,070
Atropine Sulfate	Atropine Sulfate	37	2,585	$1,664
Ofloxacin	Ofloxacin	97	2,136	$1,144

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	3	$58	Genentech USA, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	1	$107	Novartis Pharmaceuticals Corporation
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Eric Matthew Zavaleta, M.D.?

Tedicare shows public-source Medicare data for Eric Matthew Zavaleta, M.D. (NPI 1619141363), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Eric Matthew Zavaleta, M.D. have ACO affiliation data?

Eric Matthew Zavaleta, M.D. is shown with ACO affiliation data for CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Eric Matthew Zavaleta, M.D.?

Eric Matthew Zavaleta, M.D. is linked to OPHTHALMOLOGY SPECIALISTS OF TEXAS, PLLC (billing NPI 1902836166) in the available physician profile data.

Does Eric Matthew Zavaleta, M.D. have Open Payments data?

Eric Matthew Zavaleta, M.D. has 4 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.